Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Generics Bulletin

Medtech Insight

Neuraxpharm Snapped Up By Private Equity In Europe’s Largest Deal

Under Control Of Apax Partners Since 2016

Sep 22 2020

• By Dean Rudge

Neuraxpharm — Neuraxpharm was rebranded from Nupharm two years ago • Source: Shutterstock

Related Content

Perrigo Takes Another Step On Planned Generic Exit

Jun 22 2020

Neuraxpharm Buys Glenmark’s Polish CNS Assets

Feb 25 2020

Nupharm rebrands itself to Neuraxpharm

Oct 19 2018

Neuraxpharm Buccolam Acquisition Opens Up Opportunities

Sep 14 2020

Neuraxpharm Allies With Panaxia On Cannabis Portfolio

Apr 02 2020

Related Companies

Neuraxpharm Arzneimittel GmbH

Additional Topics

Europe Deals M & A Strategy Neurology

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window